Skip to main content

MoneyWorks4Me

GlaxoSmithKline Pharmaceuticals informs about institutional investors meeting

13 Mar 2023 Evaluate

Pursuant to Regulation 30(6) of the Schedule III, of the Listing Obligations and Disclosure requirements (LODR), Regulations, 2015, GlaxoSmithKline Pharmaceuticals has informed that Analyst or Institutional Meetings with the Company is schedule on 16th March 2023 at 4.30 pm to 5.45 pm virtually. Link to Join the meeting is attached.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1866.95
Dr. Reddys Labs. 1380.00
Cipla 1394.00
Lupin 1972.50
Zydus Lifesciences 1189.00
View more..